263 |
Antithrombotics After PFO Device Closure: What and How Long? |
Woong Chol Kang |
Aug. 08. 19 |
262 |
Neurologist\'s Perspective: Recent Data and Best Practices for Managing Patients |
Bum Joon Kim |
Aug. 08. 19 |
261 |
Selection of the Valve: Balloon- vs. Self-expandable Valve |
Michael Kang-Yin Lee |
Aug. 08. 19 |
260 |
Self-Expandable Evolut R & PRO Valve |
Jung-Min Ahn |
Aug. 08. 19 |
259 |
Balloon-Expandable SAPIEN 3 Valve |
Duk-Woo Park |
Aug. 08. 19 |
258 |
TAVR Challenges and Innovations in China |
Jian-an Wang |
Aug. 08. 19 |
257 |
TAVR for Bicuspid AV: Tips and Tricks |
Jung-Min Ahn |
Aug. 08. 19 |
256 |
Dedicated CT Algorithm for Optimal TAVR |
Do-Yoon Kang |
Aug. 08. 19 |
255 |
Future Perspectives for TAVR - What Is Remained? |
Eberhard Grube |
Aug. 08. 19 |
254 |
Current Status of TAVR - What We Have Achieved? |
Horst Sievert |
Aug. 08. 19 |